FDA’s Cannabidiol Crackdown: What Do Warning Letters Say About CBD In Cosmetics?
Cannabidiol (CBD) represents an intriguing opportunity for cosmetics, without the statutory obstacles faced by food and dietary supplement companies. Cosmetics marketers are taking advantage, but the FDA’s recent warning letter blitz is a reminder that CBD-infused beauty products are bound by the same rules that apply to other cosmetics.
You may also be interested in...
CIR Expert Panel To Prioritize Cannabidiol Review In 2024 At FDA’s Request
Cosmetic Ingredient Review’s independent experts note that CBD use in cosmetic products has increased since FDA first asked them to prioritize its review in 2020.
US FDA’s Stance On CBD In Cosmetics Hasn’t Changed, And Neither Have Marketing Challenges
The FDA continues working to close cannabidiol data gaps while maintaining that CBD-containing cosmetics cannot be adulterated, misbranded or marketed as affecting body structure/function or treating or preventing disease, including skin ailments. Cosmetics office head Linda Katz revisited the issue during the Independent Beauty Association’s annual FDA Cosmetics Regulations Workshop.
Environmental Working Group Awards Its ‘Verified’ Seal To First CBD Brand, Prima
The “EWG VERIFIED” mark, and Prima’s recently earned B Corp certification, should help to bolster the company’s purpose-driven, “beyond clean” claims in consumers’ esteem. At a time of regulatory uncertainty, mounting litigation and outstanding safety questions, distinguishing one’s CBD brand from bad actors and mere opportunists increasingly is the name of the game.